State of the art in surgery for early stage NSCLC—does the number of resected lymph nodes matter?
作者： Mecedes Canela Cardona , José A. Maestre Alcácer , Manuel Wong Jaen , Laura Romero Vielva
DOI: 10.3978/J.ISSN.2218-6751.2014.02.01
关键词:
摘要: Surgery is the treatment of choice in patients with early stage NSCLC. However, results remain poor these patients. Lymph node involvement main prognostic factor NSCLC, but there still no clear definition number nodes required to consider a lymphadenectomy as complete. Although defined minimum lymph for complete lymphadenectomy, are some recommendations perform this procedure, published by different scientific societies. Current practice thoracic surgery regarding differs on points from guidelines recommendations, data mediastinal assessment between 30-45% according data. Different studies have probed fact that probability finding positive increases analyzed. Therefore, provides proper staging, which helps identify patient's real prognosis. Several nonrandomized and retrospective series shown survival group higher removed. There contraindication performing lymphadenectomy. The increase may be due more accurate staging. should mandatory even
amegroups.com参考文章(35)
R Manser, D Campbell, Surgery for early stage non-small cell lung cancer. Cochrane Database of Systematic Reviews. ,(2004) , 10.1002/14651858.CD004699
Ajeet Gajra, Nancy Newman, Gary P. Gamble, Leslie J. Kohman, Stephen L. Graziano, Effect of Number of Lymph Nodes Sampled on Outcome in Patients With Stage I Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 21, pp. 1029- 1034 ,(2003) , 10.1200/JCO.2003.07.010
D LARDINOIS, P DELEYN, P VANSCHIL, R PORTA, D WALLER, B PASSLICK, M ZIELINSKI, K JUNKER, E RENDINA, H RIS, ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer European Journal of Cardio-Thoracic Surgery. ,vol. 30, pp. 787- 792 ,(2006) , 10.1016/J.EJCTS.2006.08.008
Didier Lardinois, Hans Suter, Hassan Hakki, Valentin Rousson, Daniel Betticher, Hans-Beat Ris, Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. The Annals of Thoracic Surgery. ,vol. 80, pp. 268- 275 ,(2005) , 10.1016/J.ATHORACSUR.2005.02.005
M RIQUET, D MANACH, M SAAB, F LEPIMPECBARTHES, A DUJON, B DEBESSE, Factors determining survival in resected N2 lung cancer. European Journal of Cardio-Thoracic Surgery. ,vol. 9, pp. 300- 304 ,(1995) , 10.1016/S1010-7940(05)80186-1
Sai-Hong Ignatius Ou, Jason A. Zell, Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 3, pp. 880- 886 ,(2008) , 10.1097/JTO.0B013E31817DFCED
P Goldstraw, The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer. Thorax. ,vol. 47, pp. 1- 2 ,(1992) , 10.1136/THX.47.1.1
Steven M Keller, Sudeshna Adak, Henry Wagner, David H Johnson, Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer The Annals of Thoracic Surgery. ,vol. 70, pp. 358- 365 ,(2000) , 10.1016/S0003-4975(00)01673-8
Hiroyuki Sakurai, Hisao Asamura, Shun-ichi Watanabe, Kenji Suzuki, Ryosuke Tsuchiya, Clinicopathologic features of peripheral squamous cell carcinoma of the lung The Annals of Thoracic Surgery. ,vol. 78, pp. 222- 227 ,(2004) , 10.1016/J.ATHORACSUR.2004.01.029
Raymond U. Osarogiagbon, Xinhua Yu, Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non–Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results Database Journal of Thoracic Oncology. ,vol. 7, pp. 1798- 1806 ,(2012) , 10.1097/JTO.0B013E31827457DB